CurrentEndo
Get Weekly

CurrentEndo coverage · page 36 of 55

Diabetes, Obesity and Metabolism

Briefs 1,401–1,440 of 2,200 CurrentEndo has covered from this journal, newest publication first

Latest from Diabetes, Obesity and Metabolism

All coverage, newest first

  1. Diabetes Obes Metab

    The liver fibrosis‐8 index is a predictor for all‐cause mortality in cardiovascular disease patients: A cohort study

    Cohort study

  2. Diabetes Obes Metab

    Individual and combined effects of muscle strength and visceral adiposity on incident prediabetes and type 2 diabetes in a longitudinal cohort of midlife Asian women

    Cohort studyT2D & other

  3. Diabetes Obes Metab

    iGlarLixi effectively reduces residual hyperglycaemia in Chinese people with type 2 diabetes on basal insulin: A post hoc analysis of the LixiLan ‐L‐ CN study

    Secondary analysisT2D & other

  4. Diabetes Obes Metab

    Associations of metabolic syndrome with cognitive function and dementia risk: Evidence from the UK Biobank cohort

    Cohort study

  5. Diabetes Obes Metab

    Association of metabolic score for visceral fat with all‐cause mortality, cardiovascular mortality, and cancer mortality: A prospective cohort study

    Cohort study

  6. Diabetes Obes Metab

    Metabolic risk factor targets in relation to clinical characteristics and comorbidities among individuals with type 2 diabetes treated in primary care – The countrywide cross‐sectional AUSTRO ‐ PROFIT study

    Cross-sectional studyT2D & other

  7. Diabetes Obes Metab

    Efficacy of vitamin D supplementation on glycaemic control in type 2 diabetes: An updated systematic review and meta‐analysis of randomized controlled trials

    Meta-analysisT2D & other

  8. Diabetes Obes Metab

    Key biomarkers in type 2 diabetes patients: A systematic review

    Meta-analysisT2D & other

  9. Diabetes Obes Metab

    Association of a composite trait for anthropometrics, adiposity and energy expenditure with cardiometabolic diseases: An age‐stratified cohort and genetic risk score analysis

    Diagnostic or prognostic studyT2D & other

  10. Diabetes Obes Metab

    Association of hypertension and long‐term blood pressure changes with new‐onset diabetes in the elderly: A 10‐year cohort study

    Cohort studyT2D & other

  11. Diabetes Obes Metab

    Remission and relapse of diabetes after sleeve gastrectomy and one‐anastomosis gastric bypass: The Tehran Obesity Treatment Study

    Cohort studyObesity

  12. Diabetes Obes Metab

    Mendelian randomization analysis of the association between childhood overweight or obesity and gestational diabetes mellitus

    Research articleDiabetes in pregnancy

  13. Diabetes Obes Metab

    Children and adolescent with suboptimal control of type 1 diabetes improve during the first 2 years on automated insulin delivery system

    Cohort studyTechnology

  14. Diabetes Obes Metab

    Are patients with newly diagnosed frozen shoulder more likely to be diagnosed with type 2 diabetes? A cohort study in UK electronic health records

    Cohort studyT2D & other

  15. Diabetes Obes Metab

    Glucagon‐like peptide ‐1 receptor agonist ‐based agents and weight loss composition: Filling the gaps

    Research articleObesity

  16. Diabetes Obes Metab

    Effects of glucagon‐like peptide‐1 receptor agonists on glycated haemoglobin and continuous glucose monitoring metrics as adjunctive therapy to insulin in adults with type 1 diabetes: A meta‐analysis of randomized controlled trials

    Meta-analysisT1D

  17. Diabetes Obes Metab

    Developing an automated algorithm for identification of children and adolescents with diabetes using electronic health records from the OneFlorida + clinical research network

    Diagnostic or prognostic studyT2D & other

  18. Diabetes Obes Metab

    Glycaemic control metrics and metabolic dysfunction–associated steatotic liver disease in children and adolescents with type 1 diabetes

    Cross-sectional studyT1D

  19. Diabetes Obes Metab

    Cost‐effectiveness of sodium‐glucose cotransporter‐2 inhibitors in the treatment of diabetic nephropathy in Japan

    Cohort studyComplications

  20. Diabetes Obes Metab

    Risk of hypoglycaemia among people with type 2 diabetes not treated with insulin: A retrospective analysis of Medicare Advantage beneficiaries

    Cohort studyT2D & other

  21. Diabetes Obes Metab

    Cross‐country inequalities in disease burden and care quality of chronic kidney disease due to type 2 diabetes mellitus, 1990–2021: Findings from the global burden of disease study 2021

    Secondary analysisT2D & other

  22. Diabetes Obes Metab

    Efficacy and safety of once‐weekly insulin icodec versus once‐daily basal insulin in Japanese individuals with type 2 diabetes: A subgroup analysis of the ONWARDS 1, 2 and 4 trials

    Secondary analysisT2D & other

  23. Diabetes Obes Metab

    Cost–utility analysis and drug pricing of once‐weekly insulin icodec versus once‐daily insulin degludec for type 2 diabetes patients treated with basal insulin in China

    Research articleT2D & other

  24. Diabetes Obes Metab

    The coexistence of low muscle mass and obesity evaluated by dual energy X‐ray absorptiometry, rather than low muscle mass or obesity alone, is associated with macrovascular but not microvascular complications in patients with type 2 diabetes mellitus

    Cohort studyT2D & other

  25. Diabetes Obes Metab

    Serum levels of the incretin‐like peptide 26RFa are diminished in women living with obesity and diabetes and restored after sleeve gastrectomy: Results from the prospective pilot RFa ‐Ba‐S study

    Cohort studyObesity

  26. Diabetes Obes Metab

    Global and regional estimates of hip fracture burden associated with type 1 diabetes from 1990 to 2021

    Research articleT1D

  27. Diabetes Obes Metab

    An internet‐based platform with a low‐calorie dietary intervention improves cardiometabolic risk factors in overweight and obese people in China: Half‐year follow‐up results of a randomized controlled trial

    Randomized controlled trialObesity

  28. Diabetes Obes Metab

    The interdependence of targets for continuous glucose monitoring outcomes in type 1 diabetes with automated insulin delivery

    Cohort studyTechnology

  29. Diabetes Obes Metab

    Coronary artery disease risk prediction by combined stratification of low‐density lipoprotein‐cholesterol and high‐density lipoprotein‐cholesterol levels across different glucose statuses

    Cohort studyLipids & liver

  30. Diabetes Obes Metab

    The impact of vildagliptin as an add‐on therapy on matrix metalloproteinase‐14 levels, liver stiffness and subclinical atherosclerosis in adolescents with type 1 diabetes and non‐alcoholic steatohepatitis: A randomized controlled trial

    Randomized controlled trialT1D

  31. Diabetes Obes Metab

    Cofrogliptin once every 2 weeks as add‐on therapy to metformin versus daily linagliptin in patients with type 2 diabetes in China: A randomized, double‐blind, non‐inferiority trial

    Randomized controlled trialT2D & other

  32. Diabetes Obes Metab

    Changes in insulin utilization in China from 2020 to 2022

    Research articleT2D & other

  33. Diabetes Obes Metab

    Visceral and subcutaneous adiposity and cardiovascular disease: Unravelling associations and prognostic value

    Secondary analysis

  34. Diabetes Obes Metab

    Cardiovascular phenotypes in type 2 diabetes: Latent class analysis of the CANVAS Program and CREDENCE trial

    Secondary analysisT2D & other

  35. Diabetes Obes Metab

    Diabetes mellitus and adverse clinical events in patients with atrial fibrillation: A report from the GLORIA ‐ AF registry phase III

    Cohort studyT2D & other

  36. Diabetes Obes Metab

    In which common chronic conditions can (or cannot) obesity and lifestyle factors explain higher concentrations of C‐reactive protein?

    Cross-sectional studyObesity

  37. Diabetes Obes Metab

    Psychosocial outcomes with the Omnipod® 5 Automated Insulin Delivery System in caregivers of very young children with type 1 diabetes

    Research articleT1D

  38. Diabetes Obes Metab

    Prevalence of obesity and cardiovascular disease in adults with type 2 diabetes and use of diabetes medication in Germany: A claims data study

    Cohort studyT2D & other

  39. Diabetes Obes Metab

    Association between estimated glucose disposal rate and cardiovascular mortality across the spectrum of glucose tolerance in the US population

    Cohort study

  40. Diabetes Obes Metab

    Glycaemic and weight effects of metabolic surgery or semaglutide in diabetes dosage for patients with type 2 diabetes

    Cohort studyObesity

All 2,200 Briefs in ExploreShowing Briefs 1,401–1,440 of 2,200, newest first